Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Q Lacy

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Bone Marrow Transplantation|August 5, 2000
Delayed stem cell transplantation for the management of relapsed or refractory multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Bone Marrow Transplantation|October 27, 1997
Factors influencing platelet recovery after blood cell transplantation in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
Neurology|March 17, 2010
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosisD Dingli, T S Tan, S K Kumar, et al.
Bone Marrow Transplantation|November 11, 2008
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myelomaM A Gertz, S K Kumar, M Q Lacy, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Bone Marrow Transplantation|September 11, 2001
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantationS A Capizzi, S Kumar, N E Huneke, et al.
Leukemia|February 26, 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaK Detweiler Short, S V Rajkumar, D Larson, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|August 5, 2000
Delayed stem cell transplantation for the management of relapsed or refractory multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Bone Marrow Transplantation|October 27, 1997
Factors influencing platelet recovery after blood cell transplantation in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
Neurology|March 17, 2010
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosisD Dingli, T S Tan, S K Kumar, et al.
Bone Marrow Transplantation|November 11, 2008
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myelomaM A Gertz, S K Kumar, M Q Lacy, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Bone Marrow Transplantation|September 11, 2001
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantationS A Capizzi, S Kumar, N E Huneke, et al.
Leukemia|February 26, 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaK Detweiler Short, S V Rajkumar, D Larson, et al.
Pageof 15